![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Once Daily Sofosbuvir/Ledipasvir
Fixed-Dose Combination With or Without
Ribavirin: Data From the ELECTRON Trials
|
|
|
Reported by Jules Levin
AASLD 2013 Nov 1-5 Washington DC
Edward J. Gane1, Catherine A. Stedman2, Robert H. Hyland3,
Xiao Ding3, Evguenia S. Svarovskaia3, Phil S. Pang3, William T. Symonds3
1Auckland Clinical Studies, Auckland, New Zealand; 2Christchurch Clinical Studies
Trust, Christchurch, New Zealand; 3Gilead Sciences, Inc, Foster City, CA
![AASLD1.gif](../images/110413/110413-4/AASLD1.gif)
![AASLD2.gif](../images/110413/110413-4/AASLD2.gif)
![AASLD3.gif](../images/110413/110413-4/AASLD3.gif)
![AASLD4.gif](../images/110413/110413-4/AASLD4.gif)
![AASLD5.gif](../images/110413/110413-4/AASLD5.gif)
![AASLD6.gif](../images/110413/110413-4/AASLD6.gif)
![AASLD7.gif](../images/110413/110413-4/AASLD7.gif)
![AASLD8.gif](../images/110413/110413-4/AASLD8.gif)
![AASLD9.gif](../images/110413/110413-4/AASLD9.gif)
![AASLD10.gif](../images/110413/110413-4/AASLD10.gif)
![AASLD11.gif](../images/110413/110413-4/AASLD11.gif)
![AASLD12.gif](../images/110413/110413-4/AASLD12.gif)
![AASLD13.gif](../images/110413/110413-4/AASLD13.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|